WHO Report Evaluates Ways To Fund Drug R&D For Developing Countries; Critics Say It Fails To Address Access To Medicines
This article was originally published in PharmAsia News
Executive Summary
How can governments and industry boost research and development on diseases prevalent in developing countries
You may also be interested in...
Korea's Shin Poong Seeks EMEA Special Approval For Anti-malarial Drug Pyramax
SEOUL - Local South Korean drug maker Shin Poong Pharmaceutical submitted a new drug application to the European Medicines Agency for its new artemisinin combination therapy Pyramax (pyronaridine-artesunate) for malaria
Korea's Shin Poong Seeks EMEA Special Approval For Anti-malarial Drug Pyramax
SEOUL - Local South Korean drug maker Shin Poong Pharmaceutical submitted a new drug application to the European Medicines Agency for its new artemisinin combination therapy Pyramax (pyronaridine-artesunate) for malaria
GlaxoSmithKline Offering Free Access to Potential Malaria Compounds
In another effort to boost development of malaria medicines GlaxoSmithKline is providing free public access to its library of 13,500 compounds that have shown some activity against the disease